Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 North America Blood Lancets Market, by Type
1.4.2 North America Blood Lancets Market, by End Users
1.4.3 North America Blood Lancets Market, by Country
1.5 Methodology for the research
Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.2 Market Composition and Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
Chapter 3. North America Blood Lancets Market by Type
3.1 North America Vacuum Blood Lancets Market by Country
3.2 North America Safety Blood Lancets Market by Country
3.3 North America Standard Blood Lancets Market by Country
Chapter 4. North America Blood Lancets Market by End Users
4.1 North America Homecare Market by Country
4.2 North America Hospitals and Clinics Market by Country
4.3 North America Blood Banks Market by Country
4.4 North America other End Users Market by Country
Chapter 5. North America Blood Lancets Market by Country
5.1 USA Blood Lancets Market
5.1.1 USA Blood Lancets Market by Type
5.1.2 USA Blood Lancets Market by End Users
5.2 Canada Blood Lancets Market
5.2.1 Canada Blood Lancets Market by Type
5.2.2 Canada Blood Lancets Market by End Users
5.3 Mexico Blood Lancets Market
5.3.1 Mexico Blood Lancets Market by Type
5.3.2 Mexico Blood Lancets Market by End Users
5.4 Rest of North America Blood Lancets Market
5.4.1 Rest of North America Blood Lancets Market by Type
5.4.2 Rest of North America Blood Lancets Market by End Users
Chapter 6. Company Profiles
6.1 Becton, Dickinson and Company
6.1.1 Company Overview
6.1.2 Financial Analysis
6.1.3 Segmental and Regional Analysis
6.1.4 Research & Development Expense
6.1.5 Recent strategies and developments:
6.1.5.1 Product Launches:
6.1.5.2 Acquisition and Mergers:
6.2 Medtronic PLC
6.2.1 Company overview
6.2.2 Financial Analysis
6.2.3 Segmental and Regional Analysis
6.2.4 Research & Development Expenses
6.3 Abbott Laboratories
6.3.1 Company Overview
6.3.2 Financial Analysis
6.3.3 Segmental and Regional Analysis
6.3.4 Research & Development Expense
6.4 Terumo Corporation
6.4.1 Company Overview
6.4.2 Financial Analysis
6.4.3 Segmental Analysis
6.5 Haemonetics Corporation
6.5.1 Company Overview
6.5.2 Financial Analysis
6.5.3 Segmental and Regional Analysis
6.5.4 Research & Development Expense
6.6 Nipro Corporation
6.6.1 Company Overview
6.6.2 Financial Analysis
6.6.3 Segmental and Regional Analysis
6.6.4 Research & Development Expense
6.7 Sarstedt AG & Company
6.7.1 Company Overview
6.8 F.L. Medical S.r.l.
6.8.1 Company Overview
6.9 Socorex Isba SA
6.9.1 Company Overview
6.1 PL Medical Co., LLC
6.10.1 Company Overview
Unique Offerings 